Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Scientists may be able to develop a vaccine which offers lifelong protection against Nipah virus, one of the world’s ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Marburg Virus Disease has been detected in Tanzania with nine cases reported so far - eight of those infected have sadly died ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Kipp’s aunt contracted polio in the infamous Cutter Incident. But her family sees it as a story about the ability of science ...

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond ...

Respiratory viruses are continuing to spread across the United States and such activity "is expected to continue for several ...